Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients Who underwent peripheral blood stem cell transplantation

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 7, 2009, Pages 512-515

  Yesilipek, Mehmet Akif ^a   Karasu, Gulsun Tezcan ^a   Kupesiz, Alphan ^a   Uygun, Vedat ^a   Hazar, Volkan ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Fanconi anemia; Fludarabine; Peripheral stem cell transplantation

Indexed keywords

ACICLOVIR; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; FLUDARABINE; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; LYMPHOCYTE ANTIBODY; VIDARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGRAFT; ARTICLE; CHILD; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FANCONI ANEMIA; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; IRRADIATION; MALE; MORBIDITY; MORTALITY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME; CLINICAL TRIAL; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; MULTIMODALITY CANCER THERAPY; RADIOTHERAPY;

ADOLESCENT; ANTILYMPHOCYTE SERUM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; FANCONI ANEMIA; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RADIOTHERAPY; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VIDARABINE;

EID: 67650302846     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181a1c27a     Document Type: Article

References (30)

1. Yamashita T, Nakahata T. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes. Int J Hematol. 2001;74:33-41.
2. Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anemia. Nat Rev Genet. 2001;2:446-457.
3. Meetei AR, de Winter JP, Medhurst AL, et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet. 2003;35:165-170.
4. Hoskins EE, Gunawardena RW, Habash KB, et al. Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway. Oncogene. 2008;27:4798-4808. [Epub ahead of print]
5. Auerbach AD, Rogatko A, Shroeder-Kurth TM. International Fanconi anemia registry. Relation of clinical symptoms to diepoxybutane sensitivity. Blood. 1989;73:391-396.
6. Cervenka J, Arthur D, Yasis C. Mitomycin C test for diagnostic differentiation of idiopathic aplastic anemia and Fanconi anemia. Pediatrics. 1981;67:119-127.
7. McCloy M, Almeida A, Daly P, et al. Fludarabine-based stem cell transplantation protocol for Fanconi's anemia in myelo-dysplastic transformation. Br J Haematol. 2001;112:427-429.
8. Kapelushnik J, Or R, Slavin S, et al. A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia. Bone Marrow Transplant. 1997;20:1109-1110.
9. de la Fuente J, Reiss S, McCloy M, et al. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplant. 2003;32:653-656.
10. Gluckman E, Devergie A, Schaison G, et al. Bone marrow transplantation in Fanconi anemia. Br J Haematol. 1980;45: 557-564.
11. Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol. 1983;54: 431-440.
12. Hows JM, Chapple M, Marsh JCW, et al. Bone marrow transplantation for Fanconi's anaemia: the hammersmith experience 1977-1989. Bone Marrow Transplant. 1989;4: 629-634.
13. Deeg HJ, Socie G, Schoch G, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconia anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood. 1996;87:386-392.
14. Gluckman E, Berger R, Dutreix J. Bone marrow transplantation for fanconi anemia. Semin Hematol. 1984;21:20-26.
15. Kutler DI, Singh B, Satagopan J, et al. A 20 year perspective of The International Fanconi Anemia Registry (IFAR). Blood. 2003;101:1249-1256.
16. Socie G, Devergie A, Girinski T, et al. Transplantation of Fanconi's anemia: long-term follow-up of fifty patients transplanted from a sibling donor after low dose cyclopho-sphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol. 1998;103:249-255.
17. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003;101:822-826.
18. Terenzi A, Aristei C, Aversa F, et al. Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning: preliminary results. Transplant Proc. 1996;28:3101.
19. Nagler A, Or E, Naparstek G, et al. Matched unrelated bone marrow transplantation (BMT) using a non-myeloablative conditioning regimen. Blood. 1998;92:289a.
20. Spitzer T, McAfee S, Sackstein R, et al. Induction of mixed chimerism and potent antitumor responses following non-myeloablative conditioning therapy and HLA-matched and mismatched donor bone marrow transplantation (BMT) for refractory hematologic malignancies (HM). Blood. 1998;92: 519a.
21. Slavin S, Nagler A, Naparstek G, et al. Non-myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytor-eduction for the treatment of malignant and non malignant hematologic diseases. Blood. 1998;91:756-763.
22. MacMillan ML, Weisdorf DJ, Slungaard A, et al. High probability of survival in standard risk patients with Fanconi anemia (FA) after alternate donor hematopoietic cell transplantation (HCT). Blood. 2002;100:857a.
23. George B, Mathews V, Shaji RV, et al. Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia. Bone Marrow Transplant. 2005;35:341-343.
24. Locatelli F, Zecca M, Pession A, et al. The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group. Haematologica. 2007;92:1381-1388.
25. Ayas M, Al-Jefri A, Al-Seraihi A, et al. Matched-related allogeneic stem cell transplantation in Saudi patients with Fanconi anemia: 10 year's experience. Bone Marrow Transplant. 2008;42(suppl 1):S45-S48.
26. Wagner EJ, Eapen M, Mac Millian ML, et al. Unrelated donor bone marrow transplantation for he treatment of Fanconi anemia. Blood. 2007;109:2256-2262.
27. Mohty M, Faucher C, Vey N, et al. High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation. Bone Marrow Transplant. 2000;26:251-255.
28. Guardiola P, Pasquini R, Dokal I, et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood. 2000;95:422-429.
29. Wagner JE, MacMillan ML, Auerbach AD. Hematopoietic cell transplantation for Fanconi anemia. In: Blume KG, Forman S, Appelbaum FR, eds. Thomas' Hematopoietic Cell Transplantation. 3rd ed. Oxford: Blackwell Publishing; 2004: 1483-1504.
30. Tan PL, Wagner JE, Auerbach AD, et al. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatr Blood Cancer. 2006;46:630-636.